Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital

Multidrug-resistant (MDR) Pseudomonas aeruginosa increasingly causes health care-associated infections. In this study, we determined the activity of ceftolozane-tazobactam, ceftazidime-avibactam, and cefiderocol against 223 MDR P. aeruginosa clinical isolates recovered from 2013 to 2017 at the Unive...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, C., Schultze, T., Göttig, S., Kessel, J., Schröder, A., Tietgen, M., Besier, S., Burbach, T., Häussler, S., Wichelhaus, T. A., Hack, D., Kempf, V. A. J., Hogardt, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603231/
https://www.ncbi.nlm.nih.gov/pubmed/36190424
http://dx.doi.org/10.1128/spectrum.01697-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603231/
https://www.ncbi.nlm.nih.gov/pubmed/36190424
http://dx.doi.org/10.1128/spectrum.01697-22

Ejemplares similares